Doctor indicted on diet drug fraud charge
A doctor responsible for determining whether patients who had taken the once-popular diet drug fen-phen were eligible for compensation has been indicted on charges of fraud, the Justice Department announced Tuesday.
Fen-phen, a combination of fenfluarmine and phentermine, was taken off the market in 1997 after some of the millions of people who took it developed serious heart damage. Wyeth, the company that had marketed it, established a trust to pay benefits to the people who had been injured.
In the indictment, Dr. Abdur Razzak Tai, 77, is accused of participating in a scheme to submit fraudulent fen-phen claims.
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Uncompensated Care Faces a Double Hit in Some States
- Hospital Pricing Transparency a Marketing Game Changer
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions
- Hospitals Profit On Bloodstream Infections